Latest news
Loading news…
AnGes is a biopharmaceutical company specialized in HGF plasmid, NFkB decoy oligonucleotide, and therapeutic vaccines.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Investments
5
1 exits
Monthly Visits
Available in Pro Contacts
5
Patents
0
6 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- Patents granted
- 0
- Trademarks
- 6
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $9M
Investor Activity
- Investments
- 5
- Lead investments
- 4
- Portfolio orgs
- 4
- Exits
- 1
Company Info
- Org types
- company, investor
- HQ
- Tokyo, Japan
Signals & Scores
- Trend (7d)
- 2.4
- Trend (30d)
- 3.7
- Trend (90d)
- 0
Investments by AnGes
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by AnGes
Loading columns…
0 of 0Show
Page 1 / 1
Key People at AnGes
Founder, President and CEO
5
professional contacts at AnGes
Contact execs at AnGes →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to AnGes
Loading news…
FAQs about AnGes
People who checked this page also checked these
Sectors AnGes invests & acquires in
Browse the full Acquirezy directory.